公司資料
Vaxxinity 股價、新聞與催化劑
- 股票代碼:
- VAXX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (-99.61%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, VAXX closed down 99.6% at $0.0001. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Vaxxinity was a vaccine and immunotherapy company focused on synthetic vaccine development before its business was wound down and restructured. Its story reflected the challenge of translating platform ambition into commercial value.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Vaxxinity sat in vaccine biotechnology.
商業模式特徵
The business depended on platform validation, clinical progress, and investor patience for a long-duration vaccine story.
生技產業定位
Vaxxinity is best treated as a historical vaccine-platform case rather than a live catalyst leader.
未來催化劑
- Vaxxinity’s catalysts are its vaccine platform and any strategic update that clarifies the company’s next direction. The stock needs a clearer answer on how the platform becomes value-generating.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。